E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/8/2013 in the Prospect News Structured Products Daily.

New Issue: JPMorgan priced $1.17 million return notes tied to basket of 22 stocks

By Toni Weeks

San Luis Obispo, Calif., Oct. 8 - JPMorgan Chase & Co. priced $1.17 million of 0% return notes due Oct. 22, 2014 linked to a basket of 22 common stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The basket includes the following stocks with a 6% weight each: Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Co., Zoetis Inc., Covidien plc, Perrigo Co., Mylan Inc., Valeant Pharmaceuticals International, Inc., Actavis, Inc. and Aetna Inc. It also includes the following stocks with a 3.33% weight each: Endo Health Solutions Inc., Allergan, Inc., HCA Holdings, Inc., Amarin Corp. plc, InterMune, Inc., Gilead Sciences, Inc., Ariad Pharmaceuticals, Inc., Orexigen Therapeutics, Inc., Medivation, Inc., Vertex Pharmaceuticals Inc., Rite Aid Corp. and DaVita HealthCare Partners Inc.

The payout at maturity will be (a) $1,000 multiplied by (b) one plus the basket return multiplied by (b) a basket adjustment factor of 98.6%. Because of the basket adjustment factor, investors will lose some or all of their principal if the basket return is less than 1.41988%.

The final basket level will be the average of the basket's closing levels on the five trading days ending Oct. 17, 2014.

J.P. Morgan Securities LLC is the agent.

Issuer:JPMorgan Chase & Co.
Issue:Return notes
Underlying stocks:Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Co., Zoetis Inc., Covidien plc, Perrigo Co., Mylan Inc., Valeant Pharmaceuticals International, Inc., Actavis, Inc. and Aetna Inc., with each of these weighted at 6%; Endo Health Solutions Inc., Allergan, Inc., HCA Holdings, Inc., Amarin Corp. plc, InterMune, Inc., Gilead Sciences, Inc., Ariad Pharmaceuticals, Inc., Orexigen Therapeutics, Inc., Medivation, Inc., Vertex Pharmaceuticals Inc., Rite Aid Corp. and DaVita HealthCare Partners Inc., with each of these weighted at 3.33%
Amount:$1.17 million
Maturity:Oct. 22, 2014
Coupon:0%
Price:Par
Payout at maturity:(a) $1,000 multiplied by (b) one plus the basket return multiplied by (b) a basket adjustment factor of 98.6%
Initial basket level:100
Final basket level:Average of the basket's closing levels on five trading days ending Oct. 17, 2014
Pricing date:Oct. 4
Settlement date:Oct. 9
Agent:J.P. Morgan Securities LLC
Fees:1%
Cusip:48126NWM5

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.